Chevy Chase Trust Holdings, Inc. Incyte Corp Transaction History

Chevy Chase Trust Holdings, Inc.

$32.3 Billion
Q4 2024

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 83,907 shares of INCY stock, worth $6.05 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

83,907

Previous 85,709 2.1%

Holding current value

$6.05 Million

Previous $5.67 Million 2.29%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$65.08 - $83.38 $117,274 - $150,250	-1,802 Reduced 2.1%	83,907 $5.8 Million
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $64,381 - $77,049	-1,123 Reduced 1.29%	85,709 $5.67 Million
Q2 2024 Jul 22, 2024	SELL	$51.18 - $63.75 $826,864 - $1.03 Million	-16,156 Reduced 15.69%	86,832 $5.26 Million
Q1 2024 May 03, 2024	SELL	$56.55 - $66.59 $51,969 - $61,196	-919 Reduced 0.88%	102,988 $5.87 Million
Q4 2023 Jan 24, 2024	SELL	$52.16 - $64.19 $33,434 - $41,145	-641 Reduced 0.61%	103,907 $6.52 Million
Q3 2023 Oct 23, 2023	SELL	$57.77 - $65.93 $113,922 - $130,013	-1,972 Reduced 1.85%	104,548 $6.04 Million
Q2 2023 Jul 25, 2023	SELL	$60.95 - $75.51 $62,290 - $77,171	-1,022 Reduced 0.95%	106,520 $6.63 Million
Q1 2023 May 17, 2023	BUY	$70.23 - $86.01 $7.32 Million - $8.97 Million	104,233 Added 3149.98%	107,542 $7.77 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $7.23 Million - $8.85 Million	-102,897 Reduced 96.88%	3,309 $239 Million
Q4 2022 Feb 09, 2023	SELL	$67.18 - $84.11 $438,282 - $548,733	-6,524 Reduced 5.79%	106,206 $8.53 Million
Q3 2022 Nov 04, 2022	SELL	$66.18 - $82.86 $64,459 - $80,705	-974 Reduced 0.86%	112,730 $7.51 Million
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $39,575 - $49,741	598 Added 0.53%	113,704 $8.64 Million
Q1 2022 Apr 27, 2022	BUY	$66.02 - $79.71 $33,208 - $40,094	503 Added 0.45%	113,106 $8.98 Million
Q4 2021 Jan 31, 2022	SELL	$63.34 - $74.11 $167,724 - $196,243	-2,648 Reduced 2.3%	112,603 $8.27 Million
Q3 2021 Oct 20, 2021	SELL	$68.67 - $84.02 $265,478 - $324,821	-3,866 Reduced 3.25%	115,251 $7.93 Million
Q2 2021 Jul 20, 2021	SELL	$79.87 - $87.53 $502,941 - $551,176	-6,297 Reduced 5.02%	119,117 $10 Million
Q1 2021 Apr 22, 2021	SELL	$76.02 - $100.5 $652,555 - $862,692	-8,584 Reduced 6.41%	125,414 $10.2 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $312,302 - $377,903	-3,868 Reduced 2.81%	133,998 $11.7 Million
Q3 2020 Nov 06, 2020	SELL	$85.07 - $109.69 $624,583 - $805,343	-7,342 Reduced 5.06%	137,866 $12.4 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $501,753 - $736,802	-6,764 Reduced 4.45%	145,208 $15.1 Million
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $163,193 - $222,060	2,583 Added 1.73%	151,972 $11.1 Million
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $23,591 - $30,917	323 Added 0.22%	149,389 $0
Q3 2019 Nov 20, 2019	BUY	$72.82 - $86.52 $36,118 - $42,913	496 Added 0.33%	149,066 $0
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $31,098 - $37,520	423 Added 0.29%	148,570 $12.6 Million
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $179,684 - $249,256	2,827 Added 1.95%	148,147 $11.4 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $29,191 - $34,900	499 Added 0.34%	145,320 $9.24 Million
Q3 2018 Oct 23, 2018	SELL	$61.75 - $74.23 $194,142 - $233,379	-3,144 Reduced 2.12%	144,821 $10 Million
Q2 2018 Aug 02, 2018	SELL	$60.85 - $83.98 $29,877 - $41,234	-491 Reduced 0.33%	147,965 $9.91 Million
Q1 2018 Apr 10, 2018	SELL	$83.06 - $100.98 $272,685 - $331,517	-3,283 Reduced 2.16%	148,456 $12.4 Million
Q4 2017 Jan 22, 2018	BUY	$93.56 - $116.6 $264,774 - $329,978	2,830 Added 1.9%	151,739 $14.4 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $16.3 Million - $20.6 Million	148,909	148,909 $17.4 Million

Others Institutions Holding INCY

# of Institutions

706

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Account

Chevy Chase Trust Holdings, Inc. Incyte Corp Transaction History